Evidence map›Paper›PMID 41001731›Full record

ReviewChembiochem : a European journal of chemical biology2025

Biocompatible Chemistry: A Plug-and-Play Toolbox for Chemical Biology Research.

Adam R Lovato, Zeng Lin, Qingfei Zheng

Abstract readReview
In one paragraph

Review in Chembiochem : a European journal of chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Biocompatible Chemistry: A Plug-and-Play Toolbox for Chemical Biology Research.Chembiochem : a European journal of chemical biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Adam R LovatoDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, 47907, USA.
Zeng LinDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, 47907, USA.
Qingfei ZhengDepartment of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, 47907, USA.ORCID https://orcid.org/0000-0002-8397-3507

Funding

Development of a Chemical Biology Toolbox to Investigate Histone MonoaminylationR35GM150676 · NIGMS · PURDUE UNIVERSITY · PI Qingfei Zheng · 2023 to 2026
$1.6M
NIGMS NIH HHS R35 GM150676NIH HHS R35 GM150676Purdue University
6 · The paper itself

Abstract

Chemistry is referred to as the central science that has been widely applied in biological, material, and clinical research. Specifically, chemical biology is an interdisciplinary subject, where well-designed chemical tools and approaches are employed to solve complex biological questions. In the past few decades, the development of biocompatible reactions, which include click chemistry and bioorthogonal chemistry, is one of the most significant advances in the chemical biology field. In short, biocompatible chemistry enables the cleavage and formation of chemical bonds under physiological conditions, which can be thus utilized for specific labeling of cellular biomacromolecules of interest, biomarker/target validation, signaling pathway identification, drug discovery, and so on. The plug-and-play nature of biocompatible chemistry makes it a powerful toolbox for investigating complicated biological systems and producing drug leads for clinical usages. In this article, the commonly used biocompatible reactions and the recent advances of their representative applications in chemical biology research is summarized, thus highlighting the diverse potential of biocompatible chemistry as a plug-and-play toolbox for future basic and translational studies.

Indexed as

Biocompatible MaterialsClick ChemistryDrug DiscoveryHumansBiocompatible Materialsbiocompatible chemistrybiomacromolecule labelingbiomarker validationbioorthogonal chemistryclick chemistrydrug discovery

Identifiers

PMID41001731
PMCPMC12666254

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.